Skip to content

Clinical study on quantitative evaluation of the immediate and delayed effects of Finger-pressing on latent myofascial trigger points of the upper trapezius muscle based on the MyotonPRO technique

Clinical study on quantitative evaluation of the immediate and delayed effects of Finger-pressing on latent myofascial trigger points of the upper trapezius muscle based on the MyotonPRO technique

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076079
Enrollment
Unknown
Registered
2023-09-25
Start date
2023-09-25
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain syndrome

Interventions

Gently Finger-pressing group:Lightly Finger-pressing on trigger points
Heavy Finger-pressing group:Heavy Finger-pressing on trigger points
Placebo group:Touch the skin lightly without causing localized pain

Sponsors

The First Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for latent trigger points of the upper trapezius muscle: there are obvious tension bands in the upper trapezius muscle; tense bands containing palpable high-tension nodules; Pressing on a hypertonic nodule may cause pain, with or without referred pain, but this pattern of pain is not familiar to the participant and does not reproduce the symptoms experienced. (2) at least 1 latent trigger points in the right upper trapezius muscle; Body mass index (BMI) 2 hours; is right-handed; latent trigger points pain threshold < 25N.

Exclusion criteria

Exclusion criteria: (1) Recent spontaneous or other causes of head, neck and shoulder pain; (2) Broken, scarred or skin diseases on the skin of the neck and shoulders; (3) In pregnancy (transurine pregnancy test), menstruation; (4) Recent history of relevant drug treatment (painkillers, muscle relaxants, anti-inflammatory drugs, etc.); (5) Previous chronic pain diseases, immune system diseases, allergic diseases, cognitive or functional disorders; (6) Recent other conservative or invasive treatments.

Design outcomes

Primary

MeasureTime frame
MyotonPRO;Cervical joint range of motion;visual analogue scale,VAS;Pressure Pain Threshold ,PPT;

Countries

China

Contacts

Public ContactWu Li

Hunan University of Chinese Medicine

272434694@qq.com+86 135 7485 1647

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026